Cefoxitin Sodium

CHEMBL1200530 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
449.4 g/mol
LogP
Phase
4

The sodium salt preparation of cefoxitin is administered parenterally for infections requiring both aerobic and anaerobic bacterial coverage, as well as perioperative prophylaxis. It shares the cephamycin activity spectrum of the parent compound. Renal function monitoring is necessary as the drug is primarily eliminated by the kidneys.

Moleküler Ağırlık

449,4000 g/mol

TPSA

205,00 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@@H]21.[Na+]

InChI

InChI=1S/C16H17N3O7S2.Na/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19;/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22);/q;+1/p-1/t14-,16+;/m1./s1

Molecular Formula

C16H16N3NaO7S2

HBD / HBA

2 / 9

Döndürülebilir Bağlar

8

Ağır Atomlar

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The sodium salt preparation of cefoxitin is administered parenterally for infections requiring both aerobic and anaerobic bacterial coverage, as well as perioperative prophylaxis. It shares the cephamycin activity spectrum of the parent compound. Renal function monitoring is necessary as the drug is primarily eliminated by the kidneys.

Yes, Cefoxitin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200530. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23667300. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.